BRIEF-AGTC files investigational NDA for treatment of achromatopsia
October 19, 2016 at 16:25 PM EDT
* AGTC files investigational new drug application for the treatment of Achromatopsia caused by mutations in the CNGA3 gene Source text for Eikon: Further company coverage:
